Figure 1
From: Metabolic/hypoxial axis predicts tamoxifen resistance in breast cancer
Symptoms for TMX resistance among the studied TMX-resistant group. Several symptoms were responsible for stopping TMX and/or shifting to another drug for the patients in the TMX resistant group. The red bars in this figure shows 8 of the most dominant symptoms. Metastases was the most predominant symptom (51%) followed by liver disease (35.3%) and respiratory symptoms (33.3%).
